Business
Issue of shares and Total Voting Rights
Issue of shares and Total Voting Rights.
About this update from Renalytix Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 9254Q\n Renalytix PLC\n 01 November 2021\n \n \n \n \n \n \n \n \n \n \n Renalytix plc\n \n \n (\"Renalytix\" or the \"Company\")\n \n \n \n \n \n \n Issue of shares and Total Voting Rights\n \n \n \n \n \n \n NEW YORK, November 1, 2021 - \n \n Renalytix plc (AIM: RENX) announces that it has issued and allotted 68,224 ordinary shares of 0.25 pence each in the share capital of the Company (\"Ordinary Shares\") following an exercise of options on 29 October 2021. The exercise price was 121 pence per Ordinary Share.\n \n \n \n \n \n Application has been made to the London Stock Exchange for the new Ordinary Shares to be admitted to trading on AIM. It is expected that admission of the 68,224 new Ordinary Shares to trading on AIM will become effective on, or around, 5 November 2021 (\"Admission\").\n \n \n \n \n \n Total voting rights\n \n \n \n \n \n Following Admission, the Company will have 72,308,930 Ordinary Shares in issue with each share carrying the right to one vote. The Company has no Ordinary Shares held in treasury. The total number of voting rights in the Company following Admission will therefore be 72,308,930.\n \n \n \n \n \n \n \n \n \n For further information, please contact:\n \n \n \n \n \n \n \n \n \n \n \n Renalytix plc \n \n \n \n \n \n \n \n \n www.renalytix.com\n \n \n \n \n \n \n \n \n \n James McCullough, CEO \n \n \n \n \n \n Via Walbrook PR \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Stifel (Nominated Adviser, Joint Broker)\n \n \n \n \n \n \n \n Tel: 020 7710 7600\n \n \n \n \n \n \n \n \n Alex Price / Nicholas Moore \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Investec Bank plc (Joint Broker)\n \n \n \n \n \n \n \n Tel: 020 7597 4000\n \n \n \n \n \n \n \n \n Gary Clarence / Daniel Adams \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Walbrook PR Limited\n \n \n \n \n \n \n \n Tel: 020 7933 8780 \n \n or \n \n \n [email protected]\n \n \n \n \n \n \n \n \n \n Paul McManus / Lianne Cawthorne \n \n \n \n \n Mob: 07980 541 893 / 07584 3...